In a study by Kuai et al., HDL nanodiscs were modified with a Toll-like receptor 9 (TLR9) agonist (i.e., 5′-C-phosphate-G-3′) attached to cholesterol, with the addition of tumor antigen peptides. Here, TLR9 is linked to neoplasm.